CWM
FLGT icon

Copia Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Copia Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205 Hold
10
– – ﹤0.01% 549
2026
Q1 		$159 Hold
10
– – ﹤0.01% 516
2025
Q4 		$263 Hold
10
– – ﹤0.01% 507
2025
Q3 		$226 Hold
10
– – ﹤0.01% 463
2025
Q2 		$199 Hold
10
– – ﹤0.01% 455
2025
Q1 		$169 Hold
10
– – ﹤0.01% 439
2024
Q4 		$185 Buy
+10
New +$195 ﹤0.01% 412

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Copia Wealth Management's FLGT Position: Q2 2026 in Review

Copia Wealth Management held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 10 shares worth $205. The position accounts for ﹤0.01% of the portfolio, ranked #549.

Copia Wealth Management first reported a position in FLGT in Q4 2024 and has held it in 7 quarters since. The position peaked at $263 in Q4 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Copia Wealth Management held 10 shares of Fulgent Genetics worth $205 as of Q2 2026.
  • Copia Wealth Management left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Copia Wealth Management's portfolio in Q2 2026, its #549 holding.
  • Copia Wealth Management first reported a position in Fulgent Genetics in Q4 2024 and has held it in 7 quarters since.
  • Copia Wealth Management's Fulgent Genetics position peaked at $263 in Q4 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Copia Wealth Management's 13F filing for Q2 2026, filed 18 Aug 2026.